Across the recent three months, 17 analysts have shared their insights on Veeva Sys VEEV, expressing a variety of opinions spanning from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 4 | 8 | 4 | 1 | 0 |
Last 30D | 0 | 1 | 0 | 0 | 0 |
1M Ago | 0 | 2 | 0 | 0 | 0 |
2M Ago | 2 | 3 | 2 | 0 | 0 |
3M Ago | 2 | 2 | 2 | 1 | 0 |
In the assessment of 12-month price targets, analysts unveil insights for Veeva Sys, presenting an average target of $207.53, a high estimate of $250.00, and a low estimate of $160.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 4.58%.
Understanding Analyst Ratings: A Comprehensive Breakdown
A comprehensive examination of how financial experts perceive Veeva Sys is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Scott Schoenhaus | Keybanc | Raises | Overweight | $232.00 | $210.00 |
Rishi Jaluria | RBC Capital | Raises | Outperform | $250.00 | $225.00 |
Brent Bracelin | Piper Sandler | Raises | Overweight | $220.00 | $200.00 |
Scott Schoenhaus | Keybanc | Lowers | Overweight | $210.00 | $230.00 |
David Grossman | Stifel | Maintains | Buy | $205.00 | - |
David Hynes | Canaccord Genuity | Lowers | Hold | $185.00 | $210.00 |
Saket Kalia | Barclays | Lowers | Overweight | $213.00 | $220.00 |
Ryan MacDonald | Needham | Maintains | Buy | $220.00 | - |
Brent Bracelin | Piper Sandler | Maintains | Overweight | $200.00 | - |
Anne Samuel | JP Morgan | Lowers | Neutral | $183.00 | $188.00 |
Jailendra Singh | Truist Securities | Lowers | Hold | $187.00 | $227.00 |
Jailendra Singh | Truist Securities | Maintains | Hold | $227.00 | - |
Craig Hettenbach | Morgan Stanley | Lowers | Underweight | $160.00 | $181.00 |
Gabriela Borges | Goldman Sachs | Lowers | Buy | $216.00 | $244.00 |
Brian Peterson | Raymond James | Lowers | Outperform | $200.00 | $240.00 |
Ryan MacDonald | Needham | Maintains | Buy | $220.00 | - |
Brent Bracelin | Piper Sandler | Lowers | Overweight | $200.00 | $235.00 |
Key Insights:
- Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Veeva Sys. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Veeva Sys compared to the broader market.
- Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Veeva Sys's stock. This comparison reveals trends in analysts' expectations over time.
Capture valuable insights into Veeva Sys's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
Stay up to date on Veeva Sys analyst ratings.
Discovering Veeva Sys: A Closer Look
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
Veeva Sys: Financial Performance Dissected
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Revenue Growth: Veeva Sys displayed positive results in 3 months. As of 31 October, 2023, the company achieved a solid revenue growth rate of approximately 11.61%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Health Care sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Veeva Sys's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 21.92%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 3.17%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Veeva Sys's ROA excels beyond industry benchmarks, reaching 2.59%. This signifies efficient management of assets and strong financial health.
Debt Management: Veeva Sys's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.01.
The Core of Analyst Ratings: What Every Investor Should Know
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in Benzinga Pro.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.